Skip to main content

Invitrogen, Wave Biotech, PDL Biopharma, Trellis Tech, Genedata, ChemAxon

Invitrogen, Wave Biotech to Jointly Supply Media-filled Disposable Bioreactor
Invitrogen will team with Wave Biotech to supply media-filled disposable bioreactors, Invitrogen said this week.
Through the agreement, Invitrogen will supply users of Wave Biotech's Wave Bioreactor with its GIBCO cell culture media products.
Invitrogen's standard and custom media products will be available in Wave’s O-series Cellbags, which may be customized for specific cell culture needs, the companies said.
The supply partnership is expected to "substantially reduce” preparation time and the risk for contamination, the companies said.

PDL Biopharma to Use Trellis Tech for mAb Discovery
Trellis Bioscience this week said that PDL Biopharma will use Trellis’ CellSpot technology to discover monoclonal antibodies directed against a proprietary PDL antigen.
Under the terms of the agreement, Trellis will use Antibody CellSpot to screen large populations of antibody-producing cells developed by both companies using a variety of immunization strategies. PDL Biopharma will develop and commercialize any products discovered during the collaboration, and Trellis will receive an upfront fee, milestone payments, and royalties on such products.
Further financial details were not disclosed.

Genedata, ChemAxon Integrate Lead Discovery Software
Genedata has integrated its lead-discovery software with ChemAxon’s chemical visualization technology, Genedata said this week.
The integration will join Genedata’s Hit Profiler software with ChemAxon’s MarinView, and will be used in identifying novel drug candidates.
MarinView is used for visualizing and managing chemical structure information, Genedata said, adding that the integration allows the companies to “evolve their solutions independently, yet maintain interoperability.”

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.